Thyroid Tablets Recalled Nationwide Over ‘Superpotent’ Risk
A nationwide recall has been issued for one lot of Vitruvias Therapeutics’ Thyroid Tablets, USP 30 mg after the medication was found to have the potential to be “superpotent.” The Vitruvias Therapeutics hyperthyroidism risk recall follows concerns that excessive levels of thyroid hormones could be present in the affected tablets, potentially increasing the risk of … Read more